Table 2

Association between risk factors and 1-year outcomes

VariablesPatients (n)1-year outcomes, n (%)Crude resultsAdjusted results
HR/OR (95% CI)P valuesHR/OR (95% CI)P values
All-cause death*
 Insurance status
   NRCMS10 283994 (9.7)1.32 (1.18 to 1.46)<0.00011.32 (1.17 to 1.48)<0.0001
   Self-payment2213191 (8.6)1.07 (0.90 to 1.28)0.43491.18 (0.99 to 1.42)0.0702
   UBMIS12 4451074 (8.6)RefRef
Stroke recurrence
 Insurance status
   NRCMS10 283739 (7.2)1.11 (1.01 to 1.23)0.03571.12 (1.11 to 1.37)<0.0001
   Self-payment2213129 (5.8)0.91 (0.75 to 1.09)0.30031.03 (0.86 to 1.25)0.7261
   UBMIS12 445806 (6.5)RefRef
Disability
 Insurance status
   NRCMS93983011 (32.0)1.32 (1.25 to 1.41)<0.00011.29 (1.21 to 1.39)<0.0001
   Self-payment1977619 (31.3)1.28 (1.15 to 1.42)<0.00011.27 (1.14 to 1.42)<0.0001
   UBMIS11 1172919 (26.3)RefRef
  • *Adjusted for age, mRS score, family monthly income per capita, smoking, drinking, NIHSS score on administration, cerebrovascular disease type, previous stroke or TIA, heart failure/myocardial infarction, dyslipidaemia, hospital level, antiplatelets and anticoagulants in the Cox model with consideration of the hospital’s cluster effect.

  • †Adjusted for age, mRS score, family monthly income per capita, drinking, NIHSS score on administration, previous stroke or TIA, heart failure/myocardial infarction, hypertension, diabetes mellitus, hospital level, antiplatelets and anticoagulants in the Cox model with consideration of the hospital’s cluster effect.

  • ‡Adjusted for age, sex, education, mRS score, cerebrovascular diseases type, smoking, drinking, heart failure or myocardial infarction, diabetes mellitus, hospital level, antiplatelets and anticoagulants in the generalised equation estimation model.

  • mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; NRCMS, New Rural Cooperative Medical Scheme; Ref, reference; TIA, transient ischaemic attack; UBMIS, Urban Basic Medical Insurance Scheme.